Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS^E data collection technique

References

• Antunes LC, Andersen SK, Menendez A, Arena ET, Han J, Ferreira RB, Borchers CH, Finlay BB. (2011). Metabolomics reveals phospholipids as important nutrient sources during Salmonella growth in bile in vitro and in vivo. J Bacteriol 193:4719–4725.
   PubMed Web of Science ®Google Scholar
• Aura AM, Mattila I, Seppänen-Laakso T, Miettinen J, Oksman-Caldentey KM, Orešič M. (2008). Microbial metabolism of catechin stereoisomers by human faecal microbiota: Comparison of targeted analysis and a non-targeted metabolomics method. Phytochem Lett 1:18–22.
   Web of Science ®Google Scholar
• Bateman KP, Castro-Perez J, Wrona M, Shockcor JP, Yu K, Oballa R, Nicoll-Griffith DA. (2007). MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun Mass Spectrom 21:1485–1496.
   PubMed Web of Science ®Google Scholar
• Benton HP, Want E, Keun HC, Amberg A, Plumb RS, Goldfain-Blanc F, Walther B, Reily MD, Lindon JC, Holmes E, Nicholson JK, Ebbels TM. (2012). Intra- and interlaboratory reproducibility of ultra performance liquid chromatography-time-of-flight mass spectrometry for urinary metabolic profiling. Anal Chem 84:2424–2432.
   PubMed Web of Science ®Google Scholar
• Bertram HC, Eggers N, Eller N. (2009). Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. Anal Chem 81:9188–9193.
   PubMed Web of Science ®Google Scholar
• Bezabeh T, Somorjai RL, Smith IC. (2009). MR metabolomics of fecal extracts: Applications in the study of bowel diseases. Magn Reson Chem 47 Suppl 1:S54–S61.
   Google Scholar
• Chen M, Su M, Zhao L, Jiang J, Liu P, Cheng J, Lai Y, Liu Y, Jia W. (2006). Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 5:995–1002.
   PubMed Web of Science ®Google Scholar
• Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. (2003). Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1–12.
   PubMed Web of Science ®Google Scholar
• Fukiya S, Arata M, Kawashima H, Yoshida D, Kaneko M, Minamida K, Watanabe J, Ogura Y, Uchida K, Itoh K, Wada M, Ito S, Yokota A. (2009). Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces. FEMS Microbiol Lett 293:263–270.
   PubMed Web of Science ®Google Scholar
• Griffin JL, Bollard ME. (2004). Metabonomics: Its potential as a tool in toxicology for safety assessment and data integration. Curr Drug Metab 5:389–398.
   PubMed Web of Science ®Google Scholar
• Hamilton JP, Xie G, Raufman JP, Hogan S, Griffin TL, Packard CA, Chatfield DA, Hagey LR, Steinbach JH, Hofmann AF. (2007). Human cecal bile acids: Concentration and spectrum. Am J Physiol Gastrointest Liver Physiol 293:G256–G263.
   PubMed Web of Science ®Google Scholar
• Hofmann AF. (1977). The enterohepatic circulation of bile acids in man. Clin Gastroenterol 6:3–24.
   PubMedGoogle Scholar
• Huang Q, Yin P, Wang J, Chen J, Kong H, Lu X, Xu G. (2011). Method for liver tissue metabolic profiling study and its application in type 2 diabetic rats based on ultra performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879:961–967.
   PubMed Web of Science ®Google Scholar
• Inagaki S, Noda T, Min JZ, Toyo’oka T. (2007). Metabolic profiling of rat hair and screening biomarkers using ultra performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry. J Chromatogr A 1176:94–99.
   PubMed Web of Science ®Google Scholar
• Javitt NB. (1994). Bile acid synthesis from cholesterol: Regulatory and auxiliary pathways. FASEB J 8:1308–1311.
   PubMed Web of Science ®Google Scholar
• Jia LW, Chen J, Yin PY, Lu X, Xu GW. (2008). Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics 4:183–189.
   Web of Science ®Google Scholar
• Kikuchi K, Itoh Y, Tateoka R, Ezawa A, Murakami K, Niwa T. (2010a). Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878:1662–1668.
   PubMedGoogle Scholar
• Kikuchi K, Itoh Y, Tateoka R, Ezawa A, Murakami K, Niwa T. (2010b). Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878:2997–3002.
   PubMed Web of Science ®Google Scholar
• Lameire N, Jager K, Van Biesen W, de Bacquer D, Vanholder R. (2005). Chronic kidney disease: A European perspective. Kidney Int Suppl 99:S30–S38.
   Google Scholar
• Lao YM, Jiang JG, Yan L. (2009). Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine. Br J Pharmacol 157:1128–1141.
   PubMed Web of Science ®Google Scholar
• Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. (2007). Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72:247–259.
   PubMed Web of Science ®Google Scholar
• Lindon JC, Holmes E, Nicholson JK. (2006). Metabonomics techniques and applications to pharmaceutical research & development. Pharm Res 23:1075–1088.
   PubMed Web of Science ®Google Scholar
• Lindon JC, Holmes E, Nicholson JK. (2007). Metabonomics in pharmaceutical R&D. FEBS J 274:1140–1151.
   PubMed Web of Science ®Google Scholar
• Lorenzo-Zúñiga V, Bartolí R, Planas R, Hofmann AF, Viñado B, Hagey LR, Hernández JM, Mañé J, Alvarez MA, Ausina V, Gassull MA. (2003). Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology 37:551–557.
   PubMed Web of Science ®Google Scholar
• Matoba N, Une M, Hoshita T. (1986). Identification of unconjugated bile acids in human bile. J Lipid Res 27:1154–1162.
   PubMed Web of Science ®Google Scholar
• Mori K, Nakao K. (2007). Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 71:967–970.
   PubMed Web of Science ®Google Scholar
• Nangaku M. (2004). Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern Med 43:9–17.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC, Holmes E. (1999). ‘Metabonomics’: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189.
   PubMed Web of Science ®Google Scholar
• Plumb RS, Johnson KA, Rainville P, Smith BW, Wilson ID, Castro-Perez JM, Nicholson JK. (2006). UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Commun Mass Spectrom 20:1989–1994.
   PubMed Web of Science ®Google Scholar
• Raedsch R, Stiehl A, Gundert-Remy U, Walker S, Sieg A, Czygan P, Kommerell B. (1983). Hepatic secretion of bilirubin and biliary lipids in patients with alcoholic cirrhosis of the liver. Digestion 26:80–88.
   PubMed Web of Science ®Google Scholar
• Rainville PD, Stumpf CL, Shockcor JP, Plumb RS, Nicholson JK. (2007). Novel application of reversed-phase UPLC-oaTOF-MS for lipid analysis in complex biological mixtures: A new tool for lipidomics. J Proteome Res 6:552–558.
   PubMed Web of Science ®Google Scholar
• Rhee EP, Souza A, Farrell L, Pollak MR, Lewis GD, Steele DJ, Thadhani R, Clish CB, Greka A, Gerszten RE. (2010). Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 21:1041–1051.
   PubMed Web of Science ®Google Scholar
• Robertson DG, Reily MD, Baker JD. (2007). Metabonomics in pharmaceutical discovery and development. J Proteome Res 6:526–539.
   PubMed Web of Science ®Google Scholar
• Spagou K, Wilson ID, Masson P, Theodoridis G, Raikos N, Coen M, Holmes E, Lindon JC, Plumb RS, Nicholson JK, Want EJ. (2011). HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies. Anal Chem 83:382–390.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. (2010). Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6:78–95.
   PubMed Web of Science ®Google Scholar
• Vlahcevic ZR, Pandak WM, Stravitz RT. (1999). Regulation of bile acid biosynthesis. Gastroenterol Clin North Am 28:1–25, v.
   PubMed Web of Science ®Google Scholar
• Want EJ, Wilson ID, Gika H, Theodoridis G, Plumb RS, Shockcor J, Holmes E, Nicholson JK. (2010). Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc 5:1005–1018.
   PubMed Web of Science ®Google Scholar
• Werner E, Heilier JF, Ducruix C, Ezan E, Junot C, Tabet JC. (2008). Mass spectrometry for the identification of the discriminating signals from metabolomics: Current status and future trends. J Chromatogr B Analyt Technol Biomed Life Sci 871:143–163.
   PubMed Web of Science ®Google Scholar
• Wilson ID, Nicholson JK, Castro-Perez J, Granger JH, Johnson KA, Smith BW, Plumb RS. (2005). High resolution “ultra performance” liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res 4:591–598.
   PubMed Web of Science ®Google Scholar
• Wolf G. (2006). Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70:1914–1919.
   PubMed Web of Science ®Google Scholar
• Wrona M, Mauriala T, Bateman KP, Mortishire-Smith RJ, O’Connor D. (2005). ‘All-in-one’ analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. Rapid Commun Mass Spectrom 19:2597–2602.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhao X, Liu X, Wang C, Gao P, Wang J, Li L, Gu J, Yang S, Xu G. (2006). High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res 5:554–561.
   PubMed Web of Science ®Google Scholar
• Yin P, Zhao X, Li Q, Wang J, Li J, Xu G. (2006). Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res 5:2135–2143.
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Oura H, Nakagawa H, Fukuda H. (1981a). Metabolic effects of dietary adenine in rats. Nippon Nogeik Kaishi 55:811–816.
   Google Scholar
• Yokozawa T, Oura H, Nakagawa H, Takemoto K. (1981b). Takemoto. Influence of dietary purine on the level of uric acid in the serum and urine. Nippon Eiyo Shok Gakk 34:35–41.
   Google Scholar
• Yokozawa T, Oura H, Okada T. (1982). Metabolic effects of dietary purine in rats. J Nutr Sci Vitaminol 28:519–526.
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Oura H, Zheng PD, Fukase M, Koizumi F, Kanaoka M. (1983). Metabolic effects of dietary purine and pyrimidine base in rats. Agric Boil Chem 47:1297–1304.
   Google Scholar
• Yokozawa T, Zheng PD, Oura H, Koizumi F. (1986). Animal model of adenine-induced chronic renal failure in rats. Nephron 44:230–234.
   PubMed Web of Science ®Google Scholar
• Yu HT. (2003). Progression of chronic renal failure. Arch Intern Med 163:1417–1429.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Cheng XL, Cui JH, Yan XR, Wei F, Bai X, Lin RC. (2012a). Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: A serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm. Clin Chim Acta 413:1438–1445.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Cheng XL, Wei F, Xiao XY, Sun WJ, Zhang Y, Lin RC. (2012b). Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Biomarkers 17:48–55.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Liu J, Cheng XL, Bai X, Lin RC. (2012c). Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin Chim Acta 413:642–649.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Shen X, Cheng XL, Wei F, Bai X, Lin RC. (2012d). Urinary metabonomics study on the protective effects of ergosta-4,6,8(14),22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF/MS and a novel MSE data collection technique. Process Biochem. DOI:10.1016/j.procbio.2012.07.008
   Web of Science ®Google Scholar